Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients

Cancer treatment cost in the United States

(2010) Florence K. Tangka et al.   CANCER

Cost implications of new treatments for advanced colorectal cancer

(2009) Yu-Ning Wong et al.   CANCER

Effect of Age on Survival Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer

(2009) Ilene H. Zuckerman et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Effect of Rising Chemotherapy Costs on the Cost Savings of Colorectal Cancer Screening

(2009) Iris Lansdorp-Vogelaar et al.   JNCI-Journal of the National Cancer Institute

Trends in Disparities in Receipt of Adjuvant Therapy for Elderly Stage III Colon Cancer Patients

(2009) Amy J. Davidoff et al.   MEDICAL CARE

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741

(2008) Hanna K. Sanoff et al.   JOURNAL OF CLINICAL ONCOLOGY